Oğuzhan Işılay on Stabilizing Human Blood Clotting Factor VIII
Oğuzhan Işılay, Bioinformatics Intern at Mersin Üniversity, shared on LinkedIn:
”I recently read and analyzed an interesting research paper on stabilizing Human Blood Clotting Factor VIII (FVIII) using proteins derived from tardigrades.
FVIII is a critical therapeutic protein used in the treatment of Hemophilia A, but it is highly unstable and requires strict cold-chain storage.
This creates major logistical and economic challenges, especially in low-resource settings.
The study explored whether proteins associated with desiccation tolerance in tardigrades (such as CAHS and SAHS proteins) could protect FVIII during repeated drying and rehydration cycles.
Remarkably, some tardigrade proteins preserved FVIII activity significantly better than commonly used stabilizers like trehalose, even after multiple stress cycles.
What I found particularly interesting is the broader implication: bio-inspired stabilization strategies could reduce cold-chain dependency and improve global access to protein-based therapeutics.
This analysis reinforced how concepts from extremophile biology can be directly translated into real-world biotechnological and medical solutions.
Reference.”
Read the full article here.
Article: Natural and engineered mediators of desiccation tolerance stabilize Human Blood Clotting Factor VIII in a dry state
Authors: Maxwell H. Packebush, Silvia Sanchez-Martinez, Sourav Biswas, Shraddha KC, Kenny H. Nguyen, John F. Ramirez, Vincent Nicholson, Thomas C. Boothby

Stay updated on all scientific advances with Hemostasis Today.
-
Apr 11, 2026, 13:51David McIntosh: Vital Plasma Derived Medicines – The Anomalous UK Scene
-
Apr 11, 2026, 13:47Samrawit Terefe: O Negative Blood Is the Universal Donor With Extreme Scarcity
-
Apr 11, 2026, 13:39Dheeraj Garg: Rethinking Cardiovascular Disease – A Cardiologist’s Perspective
-
Apr 11, 2026, 13:37Kushal Bhatia: Is The 4.5-Hour Thrombolysis Window Officially Outdated?
-
Apr 11, 2026, 13:35William Aird: Why Did Mammalian Red Blood Cells Give Up Their Nucleus?
-
Apr 11, 2026, 13:30Ken Kuang: Gravity Is Constant, But Your Vein Health Doesn’t Have to Be
-
Apr 11, 2026, 13:21Mascha Kern: Measuring Gender’s Role in Stroke and Migraine
-
Apr 11, 2026, 13:10Danique Steeghs: Key Findings from a Microfluidic Chemiluminescent Thrombin Generation Assay
-
Apr 11, 2026, 13:06Shanvi Mahi: A Validated Tool to Explore Lived Experiences After Stroke Rehabilitation